OncoSec Medical Inc. , a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference at the University Club in New York, New York on Monday, March 3rd at 12:05 p.m.
from Content Keyword RSS http://ift.tt/1jwsQB6
via IFTTT
from Content Keyword RSS http://ift.tt/1jwsQB6
via IFTTT
No comments:
Post a Comment